Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.52 |
| ▸ | XDH | P47989 | 1/20 | 0.50 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.50 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | PGR | P06401 | 3/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.47 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.47 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.47 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.47 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.46 |
| ▸ | P4HB | P07237 | 1/20 | 0.45 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 2/20 | 0.45 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27787243 | 0.87 | CLK4 (0.63) | CLK4XDHSLC22A12PTPN5PGR | |
| SCHEMBL783352 | 0.86 | CLK4 (0.53) | CLK4XDHSLC22A12PTPN5PGR | |
| SCHEMBL21189130 | 0.85 | CLK4 (0.57) | CLK4XDHSLC22A12PTPN5PGR | |
| Hydrochloric Acid SCHEMBL28007259 | 0.85 | CLK4 (0.61) | CLK4XDHSLC22A12PTPN5PGR | |
| SCHEMBL2154026 | 0.85 | CLK4 (0.65) | CLK4XDHSLC22A12PTPN5PGR | |
| SCHEMBL26910409 | 0.84 | CLK4 (0.52) | CLK4XDHSLC22A12PTPN5PGR | |
| SCHEMBL21921980 | 0.84 | CLK4 (0.52) | CLK4XDHSLC22A12PTPN5PGR | |
| SCHEMBL29425207 | 0.83 | GABRG2 (0.61) | CLK4XDHSLC22A12PTPN5GABRG2 | |
| SCHEMBL270874 | 0.83 | GABRG2 (0.61) | CLK4XDHSLC22A12PTPN5GABRG2 | |
| SCHEMBL29511815 | 0.82 | XDH (0.56) | CLK4XDHSLC22A12PTPN5PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE50748-E1 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2026-01-06 | — | — | US | disclosed |
| CN-113728454-B | Compound, organic semiconductor material comprising the same, organic electronic device comprising the same, and display device and lighting device comprising the same | 诺瓦尔德股份有限公司 | 2024-09-24 | — | — | CN | disclosed |
| US-11827615-B2 | Nitrogen-containing compound, electronic element and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-11-28 | — | — | US | disclosed |
| US-11827615-B2 | Nitrogen-containing compound, electronic element and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-11-28 | — | — | US | disclosed |
| US-11700768-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2023-07-11 | — | — | US | disclosed |
| US-11700768-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2023-07-11 | — | — | US | disclosed |
| CN-110177778-B | Novel compound and organic light emitting device including the same | 株式会社LG化学 | 2023-06-06 | — | — | CN | disclosed |
| US-RE49343-E1 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2022-12-20 | — | — | US | disclosed |
| US-20220216428-A1 | SEE ADDENDUM | NOVALED GMBH (DE) | 2022-07-07 | — | — | US | disclosed |
| EP-3726599-B1 | COMPOUND, ORGANIC SEMICONDUCTING MATERIAL COMPRISING THE SAME, ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME, AND DISPLAY DEVICE AND LIGHTING DEVICE COMPRISING THE SAME | NOVALED GMBH (DE) | 2022-03-23 | — | — | EP | disclosed |
| US-20130234119-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2013-09-12 | — | — | US | disclosed |
| US-20130234119-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2013-09-12 | — | — | US | disclosed |
| US-7473790-B2 | Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same | PFIZER INC. (US) | 2009-01-06 | — | — | US | disclosed |
| US-7473790-B2 | Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same | PFIZER INC. (US) | 2009-01-06 | — | — | US | disclosed |
| US-7473790-B2 | Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same | PFIZER INC. (US) | 2009-01-06 | — | — | US | disclosed |
| US-7148226-B2 | Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same | AGOURON PHARMACEUTICALS, INC. (US) | 2006-12-12 | — | — | US | disclosed |
| US-20060189681-A1 | INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME | AGOURON PHARMACEUTICALS, INC. | 2006-08-24 | — | — | US | disclosed |
| EP-1597246-A2 | INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME | PFIZER INC. (US) | 2005-11-23 | — | — | EP | disclosed |
| US-20050176701-A1 | Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same | AGOURON PHARMACEUTICALS, INC. | 2005-08-11 | — | — | US | disclosed |
| WO-2004074270-A2 | INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME | PFIZER INC. (US) | 2004-09-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11700768-B2 | Compound and organic light emitting device comprising the same | ARL1, ARRB1, CRY1 | CLK4 2560/4885XDH 201/4885SLC22A12 4141/4885 |
| US-11827615-B2 | Nitrogen-containing compound, electronic element and electronic device | NOS1, PRMT1, MNS1 | CLK4 3808/4885XDH 2195/4885SLC22A12 1931/4885 |
| US-20060189681-A1 | INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME | RNASE1, RNASEH1, NSUN3 | CLK4 4124/4885XDH 438/4885SLC22A12 3069/4885 |
| US-20050176701-A1 | Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same | RNASE1, RNASEH1, NSUN3 | CLK4 4124/4885XDH 438/4885SLC22A12 3069/4885 |
| US-20220216428-A1 | SEE ADDENDUM | NECTIN4, GET3, CPNE4 | CLK4 892/4885XDH 3705/4885SLC22A12 3731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.